LIDDS continues to grow with new hire to manage pre-clinical trials

NEXT STORY
G1 Therapeutics Announces Updated Results from Phase 2 Trial of Trilaciclib in Combination with Chemotherapy Showed Statistically Significant Improvement in Overall Survival in Women with Metastatic Triple-Negative Breast Cancer
PREV STORY
Japan becomes the first country to approve Roche’s personalised medicine Rozlytrek
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Elsalys Biotech : New studies confirm anti-CD160 potential in ophthalmology

New studies confirm anti-CD160 antibodies are potential therapeutics for ophthalmic diseases Efficacy and safety ...

author_avatar
NASDAQ Market News

Global Molecular Diagnostics Market Gaining Momentum—Projected to Reach worth USD 31.98 Billion in 2027

author_avatar
NASDAQ Market News

BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021

author_avatar
NASDAQ Market News